版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
TheEPshow:
Riskstratificationforsuddendeath
TheEPshow:
RiskstratificatiRiskstratificationforsuddendeathRiskstratificationforsuddenHistoricallookatearlymarkersBeganduringthemid-1980swithaprospectivestudyofabout1000postinfarctionpatients
Measured24-hourHolterrecordingsforventricularprematurebeatfrequency
Determinedejectionfraction
Ascertainedseveralother
routineclinicalparametersMossHistoricallookatearlymarkeHistoricallookatearlymarkersFoundinverserelationshipbetweentheejectionfractionandtotalmortalityaswellassuddendeath
Cutpointbetween30%and40%
Recentstudies,includingMADITI
andII,grewoutofthisearlyworkMossHistoricallookatearlymarkeSerialelectrophysiologytestingMechanisticallydriven
Suddendeathinpostinfarctionpatientspredominatelyduetoventriculartachycardia
Ifyoucouldinduceventriculartachycardiaandintroduceadrugthatsuppressesthisability,youcouldmonitorefficacyGoldSerialelectrophysiologytestiReviewingCASTCardiacArrhythmiaSuppressionTrial(CAST)
LargerandomizedtrialthatlookedatwhethersuppressingventricularectopyafterMIreducessuddendeathTrialstoppedbecauseantiarrhythmicagentsassociatedwithincreasedmortalityReviewingCASTCardiacArrhythmReviewingCAST"Thissetthestageformovingfromantiarrhythmicagentstodevicetherapy."MossReviewingCAST"ThissetthestReviewingCASTCouldtheseresultsberelatedtothedrugsselected?
SubsequenttrialsconfirmedthatthiswasnotthecasePrystowskyReviewingCASTCouldtheseresuMADITIWouldanICDorconventionaltherapyimprovesurvivalinthishigh-riskpopulation?
Randomlyassigned196patientswithpriorMIand:
NYHAfunctionalclass1,2,or3
Aleftventricularejectionfraction<35%
Anepisodeofasymptomaticunsustainedventriculartachycardia
Inducible,nonsuppressibleventriculartachyarrhythmiaonelectrophysiologicstudyMADITIWouldanICDorconventMADITIfindingsGroupTotaldeathsCardiacdeathsDefibrillator1511Conventionaltherapy3927*Average27-monthfollow-up
MADITIfindingsGroupTotaldeaMADITIInhigh-riskpatientswithpriorMI,prophylactictherapywithanICDleadstoimprovedsurvivalcomparedwithconventionalmedicaltherapyMADITIInhigh-riskpatientswMUSTT
MulticenterUnsustainedTachycardiaTrial(MUSTT),arandomizedcontrolledtrial
Canelectrophysiologicallyguidedantiarrhythmictherapyreducetheriskofsuddendeath?
Lookedatcoronaryarterydiseasepatientswithaleftventricularejectionfraction<40%andasymptomaticunsustainedventriculartachycardiaMUSTT
MulticenterUnsustainedMUSTTEndpointCardiacarrestor
arrhythmiadeathEP-guided
therapy(%)25Noantiarrhythmic
therapy(%)32Relativerisk0.7395%CI0.53-0.99MUSTTEndpointCardiacarrestoMUSTTTherapywithimplantabledefibrillators,butnotwithantiarrhythmicdrugs,reducestheriskofsuddendeathinhigh-riskpatientswithcoronarydisease
MUSTTTherapywithimplantableUnsustainedVT"Ithinkit'sarelativelyweakriskstratifier.Andasyoupointout,itwasbothfrustratingandcumbersome."GoldUnsustainedVT"Ithinkit'saMADITIIRandomizedtrialevaluatingtheeffectofanimplantabledefibrillatoronsurvival
1232patientswithpriorMIandaleftventricularejectionfractionof<30%
Patientsrandomlyassignedina3:2ratiotoreceiveICDorconventionalmedicaltherapyMADITIIRandomizedtrialevaluMADITmortalityratesMADITmortalityratesMADITII"Thisreallyintroducedasimplifiedstratificationapproach."MossMADITII"ThisreallyintroduceMADITIIandCMS"TheytookaconservativepositionandsaidthattheyweregoingtoreimburseonlyforMADITIIpatientswhohadaQRSduration>120millisecondsandthattheywouldrevisitthiswhenSCD-HeFTdatawerepresented."MossMADITIIandCMS"TheytookacSCD-HeFTSuddenCardiacDeathinHeartFailureTrial(SCD-HeFT)
LargestofthetrialsinvolvingICDtherapywithalongerpatientfollow-upthanpreviousstudies
SCD-HeFTSuddenCardiacDeathiSCD-HeFTComparedall-causemortalityin
>2500patients
WithNYHAclass2to3HF
LVEF<35%
PatientsrandomizedtoreceiveICD,amiodarone,orplaceboontopofstandardmedicaltherapySCD-HeFTComparedall-causemorSCD-HeFTall-causemortality
SCD-HeFTall-causemortality
SCD-HeFTICDcutsall-causemortalityby23%in
NYHAclass2to3heartfailure
SCD-HeFTICDcutsall-causemorWhat'sapayertodo?"Thetrialsweredesignedspecificallytoanswerthemajorquestionofdefibrillatorsandtheirroletoreducetotalmortality.Ithinkthetrials,asyoupointout,areconcordantinthatregard,andIthinkthatitwouldbereasonablethatthatwouldbeanindicationforpaying."GoldWhat'sapayertodo?"ThetriaWhat'sapayertodo?"Gettingintosubsetswhenit'snotreallyprespecifiedthat'swhatyou'relookingforispotentiallyverytreacherousandcanbemisleading."MossWhat'sapayertodo?"GettingThefutureManyhavebecomecynicalasnoninvasivetestafternoninvasivetestfailedtoliveuptoitsexpectations
ButIremainoptimisticGoldThefutureManyhavebecomecynQuestionAretherepatientsinMADITIIwhoare:
"Toohealthy"tobenefitfromanICD?
"Toosick"forone?PrystowskyQuestionAretherepatientsinLatestlookatMADITIIThebenefitfromICDwasentirelyinthepatientswhocarriedoneormoreriskfactors
The20%ofthepopulationthatcarriednoriskfactorsachievednobenefitwhatsoeverMossLatestlookatMADITIIThebeSummarySeveraldecadesofresearchhaveputriskstratifierstothetest
Ejectionfractionremainssupremeasanoninvasivetest
We'veidentifiedthebenefactorsofICDtherapy
AndrealizedthatantiarrhythmicdrugstopreventsuddendeatharenotasimportantasoncethoughtSummarySeveraldecadesofreseInconclusionDespite
somanynoninvasivetestsfailingtoliveupto
expectations,
manystillshowpromiseHotoffthepress!Newsoon-to-be-publisheddatawillshowthatcombinationsofriskstratifiersmayhelppinpointpatientswhowillderivethemostandleastbenefitfromanICDPrystowskyInconclusionDespite
somanynTheEPshow:
Riskstratificationforsuddendeath
TheEPshow:
RiskstratificatiRiskstratificationforsuddendeathRiskstratificationforsuddenHistoricallookatearlymarkersBeganduringthemid-1980swithaprospectivestudyofabout1000postinfarctionpatients
Measured24-hourHolterrecordingsforventricularprematurebeatfrequency
Determinedejectionfraction
Ascertainedseveralother
routineclinicalparametersMossHistoricallookatearlymarkeHistoricallookatearlymarkersFoundinverserelationshipbetweentheejectionfractionandtotalmortalityaswellassuddendeath
Cutpointbetween30%and40%
Recentstudies,includingMADITI
andII,grewoutofthisearlyworkMossHistoricallookatearlymarkeSerialelectrophysiologytestingMechanisticallydriven
Suddendeathinpostinfarctionpatientspredominatelyduetoventriculartachycardia
Ifyoucouldinduceventriculartachycardiaandintroduceadrugthatsuppressesthisability,youcouldmonitorefficacyGoldSerialelectrophysiologytestiReviewingCASTCardiacArrhythmiaSuppressionTrial(CAST)
LargerandomizedtrialthatlookedatwhethersuppressingventricularectopyafterMIreducessuddendeathTrialstoppedbecauseantiarrhythmicagentsassociatedwithincreasedmortalityReviewingCASTCardiacArrhythmReviewingCAST"Thissetthestageformovingfromantiarrhythmicagentstodevicetherapy."MossReviewingCAST"ThissetthestReviewingCASTCouldtheseresultsberelatedtothedrugsselected?
SubsequenttrialsconfirmedthatthiswasnotthecasePrystowskyReviewingCASTCouldtheseresuMADITIWouldanICDorconventionaltherapyimprovesurvivalinthishigh-riskpopulation?
Randomlyassigned196patientswithpriorMIand:
NYHAfunctionalclass1,2,or3
Aleftventricularejectionfraction<35%
Anepisodeofasymptomaticunsustainedventriculartachycardia
Inducible,nonsuppressibleventriculartachyarrhythmiaonelectrophysiologicstudyMADITIWouldanICDorconventMADITIfindingsGroupTotaldeathsCardiacdeathsDefibrillator1511Conventionaltherapy3927*Average27-monthfollow-up
MADITIfindingsGroupTotaldeaMADITIInhigh-riskpatientswithpriorMI,prophylactictherapywithanICDleadstoimprovedsurvivalcomparedwithconventionalmedicaltherapyMADITIInhigh-riskpatientswMUSTT
MulticenterUnsustainedTachycardiaTrial(MUSTT),arandomizedcontrolledtrial
Canelectrophysiologicallyguidedantiarrhythmictherapyreducetheriskofsuddendeath?
Lookedatcoronaryarterydiseasepatientswithaleftventricularejectionfraction<40%andasymptomaticunsustainedventriculartachycardiaMUSTT
MulticenterUnsustainedMUSTTEndpointCardiacarrestor
arrhythmiadeathEP-guided
therapy(%)25Noantiarrhythmic
therapy(%)32Relativerisk0.7395%CI0.53-0.99MUSTTEndpointCardiacarrestoMUSTTTherapywithimplantabledefibrillators,butnotwithantiarrhythmicdrugs,reducestheriskofsuddendeathinhigh-riskpatientswithcoronarydisease
MUSTTTherapywithimplantableUnsustainedVT"Ithinkit'sarelativelyweakriskstratifier.Andasyoupointout,itwasbothfrustratingandcumbersome."GoldUnsustainedVT"Ithinkit'saMADITIIRandomizedtrialevaluatingtheeffectofanimplantabledefibrillatoronsurvival
1232patientswithpriorMIandaleftventricularejectionfractionof<30%
Patientsrandomlyassignedina3:2ratiotoreceiveICDorconventionalmedicaltherapyMADITIIRandomizedtrialevaluMADITmortalityratesMADITmortalityratesMADITII"Thisreallyintroducedasimplifiedstratificationapproach."MossMADITII"ThisreallyintroduceMADITIIandCMS"TheytookaconservativepositionandsaidthattheyweregoingtoreimburseonlyforMADITIIpatientswhohadaQRSduration>120millisecondsandthattheywouldrevisitthiswhenSCD-HeFTdatawerepresented."MossMADITIIandCMS"TheytookacSCD-HeFTSuddenCardiacDeathinHeartFailureTrial(SCD-HeFT)
LargestofthetrialsinvolvingICDtherapywithalongerpatientfollow-upthanpreviousstudies
SCD-HeFTSuddenCardiacDeathiSCD-HeFTComparedall-causemortalityin
>2500patients
WithNYHAclass2to3HF
LVEF<35%
PatientsrandomizedtoreceiveICD,amiodarone,orplaceboontopofstandardmedicaltherapySCD-HeFTComparedall-causemorSCD-HeFTall-causemortality
SCD-HeFTall-causemortality
SCD-HeFTICDcutsall-causemortalityby23%in
NYHAclass2to3heartfailure
SCD-HeFTICDcutsall-causemorWhat'sapayertodo?"Thetrialsweredesignedspecificallytoanswerthemajorquestionofdefibrillatorsandtheirroletoreducetotalmortality.Ithinkthetrials,asyoupointout,areconcordantinthatregard,andIthinkthatitwouldbereasonablethatthatwouldbeanindicationforpaying."GoldWhat'sapayertodo?"ThetriaWhat'sapayertodo?"Gettingintosubsetswhenit'snotreallyprespecifiedthat'swhatyou'relookingforispotentiallyverytreacherousandca
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度建筑材料購銷合同范本與范文
- 公司商標特定產(chǎn)品授權(quán)合同書版B版
- 2025年度區(qū)塊鏈技術(shù)應(yīng)用合資合同協(xié)議書
- 2025年度鍋爐設(shè)備性能優(yōu)化合同
- 全新破碎機買賣合同下載(2024版)
- 2025年總經(jīng)理聘用協(xié)議:海洋經(jīng)濟產(chǎn)業(yè)高層管理人員聘用合同
- 2025年度海底光纜鋪設(shè)與維護服務(wù)采購合同
- 二零二五年度高端廚房設(shè)備安裝與維護服務(wù)合同2篇
- 二零二五年度個人別墅買賣合同示范書3篇
- 二零二五年度房地產(chǎn)開發(fā)項目承包合同補充協(xié)議書3篇
- 再見深海合唱簡譜【珠海童年樹合唱團】
- 高中物理 選修1 第四章 光(折射反射干涉衍射偏振)(2024人教版)
- 《聚焦客戶創(chuàng)造價值》課件
- PTW-UNIDOS-E-放射劑量儀中文說明書
- 保險學(xué)(第五版)課件全套 魏華林 第0-18章 緒論、風(fēng)險與保險- 保險市場監(jiān)管、附章:社會保險
- 許小年:淺析日本失去的30年-兼評“資產(chǎn)負債表衰退”
- 典范英語2b課文電子書
- 17~18世紀意大利歌劇探析
- β內(nèi)酰胺類抗生素與合理用藥
- 何以中國:公元前2000年的中原圖景
- 第一章:公共政策理論模型
評論
0/150
提交評論